Catimanan, Rizal -.
HRN: 26-38-72 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/22/2025
CEFUROXIME 750MG (VIAL)
10/22/2025
10/29/2025
IV
310mg
Q8
PCAP C
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: PneumoniaProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes